Mechanism
PDE3 (phosphodiesterase 3) and HMG-CoA reductase
Assets acting on this target.
- Class
- Combination of PDE3 inhibitor (cilostazol) and statin (rosuvastatin)
- Notes
- verified in session 2026-08-25 (owner-delegated review); source: https://clinicaltrials.gov/study/NCT07600385